Orlistat
KGDobesity
Empros Pharma AB · Phase 2 · Status n/r · Enrollment 150
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Ketogenic diet, lifestyle counseling | n/r | n/r | n/r | n/r |
| Orlistat, Lifestyle counseling | n/r | n/r | n/r | n/r |
| Standartized diet, Lifestyle counseling | n/r | n/r | n/r | n/r |
Not shown
- Ketogenic diet, lifestyle counseling: endpoint not reported
- Orlistat, Lifestyle counseling: endpoint not reported
- Standartized diet, Lifestyle counseling: endpoint not reported